Free Trial
NASDAQ:IVVD

Invivyd (IVVD) Stock Price, News & Analysis

Invivyd logo
$1.88 +0.12 (+6.82%)
Closing price 04:00 PM Eastern
Extended Trading
$1.86 -0.02 (-1.33%)
As of 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Invivyd Stock (NASDAQ:IVVD)

Advanced

Key Stats

Today's Range
$1.64
$1.90
50-Day Range
$0.52
$1.89
52-Week Range
$0.35
$2.74
Volume
5.37 million shs
Average Volume
7.64 million shs
Market Capitalization
$403.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.14
Consensus Rating
Moderate Buy

Company Overview

Invivyd Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

IVVD MarketRank™: 

Invivyd scored higher than 70% of companies evaluated by MarketBeat, and ranked 299th out of 948 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Invivyd has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 4 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Invivyd has a consensus price target of $5.14, representing about 187.8% upside from its current price of $1.79.

  • Amount of Analyst Coverage

    Invivyd has only been the subject of 4 research reports in the past 90 days.

  • Read more about Invivyd's stock forecast and price target.
  • Earnings Growth

    Earnings for Invivyd are expected to grow in the coming year, from ($1.64) to $0.11 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Invivyd is -1.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Invivyd is -1.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Invivyd has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Invivyd's valuation and earnings.
  • Percentage of Shares Shorted

    4.69% of the float of Invivyd has been sold short.
  • Short Interest Ratio / Days to Cover

    Invivyd has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Invivyd has recently increased by 37.76%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Invivyd does not currently pay a dividend.

  • Dividend Growth

    Invivyd does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.69% of the float of Invivyd has been sold short.
  • Short Interest Ratio / Days to Cover

    Invivyd has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Invivyd has recently increased by 37.76%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Invivyd has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Invivyd this week, compared to 4 articles on an average week.
  • Search Interest

    Only 31 people have searched for IVVD on MarketBeat in the last 30 days. This is a decrease of -11% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Invivyd to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Invivyd insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $167,215.00 in company stock.

  • Percentage Held by Insiders

    25.40% of the stock of Invivyd is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    70.36% of the stock of Invivyd is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Invivyd's insider trading history.
Receive IVVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invivyd and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IVVD Stock News Headlines

Analysts Set Invivyd, Inc. (NASDAQ:IVVD) Target Price at $4.89
October 16 Changes the Microchip Game — and Investing
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
Cantor Fitzgerald Initiates Coverage on Invivyd (NASDAQ:IVVD)
See More Headlines

IVVD Stock Analysis - Frequently Asked Questions

Invivyd's stock was trading at $0.4431 on January 1st, 2025. Since then, IVVD shares have increased by 302.8% and is now trading at $1.7850.

Invivyd, Inc. (NASDAQ:IVVD) issued its earnings results on Thursday, August, 14th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $0.08. The company had revenue of $11.79 million for the quarter, compared to analysts' expectations of $23.16 million. Invivyd had a negative net margin of 238.33% and a negative trailing twelve-month return on equity of 177.89%.

Shares of IVVD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invivyd investors own include American Water Works (AWK), The RMR Group (RMR), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
8/14/2025
Today
10/13/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IVVD
CIK
1832038
Fax
N/A
Employees
100
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$2.00
Potential Upside/Downside
+191.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$169.93 million
Net Margins
-238.33%
Pretax Margin
-238.33%
Return on Equity
-177.89%
Return on Assets
-90.96%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.33
Quick Ratio
1.33

Sales & Book Value

Annual Sales
$25.38 million
Price / Sales
14.87
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.56 per share
Price / Book
3.14

Miscellaneous

Outstanding Shares
214,410,000
Free Float
159,949,000
Market Cap
$377.36 million
Optionable
Optionable
Beta
0.57
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:IVVD) was last updated on 10/13/2025 by MarketBeat.com Staff
From Our Partners